source
- RegCell secures multi-million dollar Series A to advance Nobel-winning regulatory T-cell therapyRegCell, a biotech founded by Nobel laureate Shimon Sakaguchi, announced a new financing round to move its regulatory T-cell (Treg) program toward clinical testing. The company’s CEO Michael McCul…
- FDA launches expedited IND pilot program, integrating public feedback into qualification criteriaThe FDA announced that its long-awaited expedited investigational new drug (IND) pilot program has started accepting applications as of Tuesday. Agency leaders Karim Mikhail and Michael Davis, new…